Loading... 2 0 5 0 false
Credit Name
Ashray Gunjur
Full Name
Gunjur, Ashray
 
Department
 
Loading... 3 0 5 0 false

Publications

Results 1-7 of 7 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
1Jan-2021Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K 
212-Nov-2020Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results.Balasubramanian, Adithya ; Onggo, James; Gunjur, Ashray ; John, Thomas ; Parakh, Sagun 
314-Sep-2020Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.Gunjur, Ashray ; Chazan, Grace; Newnham, Genni; McLachlan, Sue-Anne
4Sep-2020Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.Balasubramanian, Adithya ; Gunjur, Ashray ; Gan, Hui Kong; Perchyonok, Yuliya ; Cher, Lawrence M 
5Sep-2020Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.Balasubramanian, Adithya ; Gunjur, Ashray ; Gan, Hui K ; Perchyonok, Yuliya ; Cher, Lawrence M 
6Mar-2020Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.Gunjur, Ashray ; Chong, Geoffrey ; Lim, Adeline ; Lau, Eddie ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein
75-Sep-2019Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature.Gunjur, Ashray ; Klein, Oliver ; Kee, Damien ; Cebon, Jonathan S